Results 311 to 320 of about 880,199 (399)

ST-Segment-Elevation Acute Coronary Syndrome in a Patient With a Superdominant Right Coronary Artery and a Coincident Absent Left Circumflex Artery. [PDF]

open access: yesCureus
Ramcharan P   +8 more
europepmc   +1 more source

The Thigh Saphenous Vein Versus the Calf Saphenous Vein: Searching for the Optimal Conduit for Coronary Artery Bypass Grafting

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The quality of saphenous vein (SV) grafts can vary depending on the site from which they are harvested. However, few studies have compared SV grafts harvested from the thigh with those harvested from the calf to explore which is more appropriate for use in coronary artery bypass grafting (CABG). In this study, we evaluated the graft
Aidong Chen, Ke Pan
wiley   +1 more source

A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The treatment of coronary bifurcation lesions (CBL) remains complex and associated with a higher rate of long‐term adverse cardiovascular events due to anatomical and procedural complexity. Aims We compared procedural outcomes between a drug coated balloon (DCB) only approach and a 2nd generation drug eluting stent (DES) for ...
Natasha Corballis   +20 more
wiley   +1 more source

Intentional Stent Fracture to Accommodate Growth After Coarctation Stenting in an 860‐g Neonate

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Congenital aortic coarctation in neonates and children can be managed with transcatheter stent implantation, but this approach raises the issue of how to accommodate the fixed stent structure within the growing vessel. Case Summary A 15‐month‐old boy, born prematurely with critical aortic coarctation, was treated at 1 week of age ...
Magdalena Cuman   +3 more
wiley   +1 more source

Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Antiangiogenic therapy with bevacizumab improves outcomes in ovarian cancer but induces hypertension, leading to major adverse cardiovascular events (MACE). While calcium channel blockers (CCBs) and angiotensin‐converting enzyme inhibitors (ACEi) are recommended for managing bevacizumab‐associated hypertension, their impacts on cancer progression and ...
Floriane Jochum   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy